Table 4. Comparison of TMZ effects on hearts subjected to AHF—Isolated from lean and obese males (n = 6).
| Control | ||||||
| Lean | Obese | Sig. | ||||
| Heart rate (%) |
210.13 ± 127.11 | 31.75 ± 2.85 | ns | |||
| LVDevP (%) |
1259.06 ± 485.90 | 2411.10 ± 458.16 | ns | |||
| LVEDP (%) |
201.85 ± 36.57 | 142.48 ± 10.43 | ns | |||
| LVESP (%) |
211.06 ± 43.49 | 147.98 ± 11.77 | ns | |||
| TMZ at CAHF | TMZ at RAHF | |||||
| Lean | Obese | Sig. | Lean | Obese | Sig. | |
| Heart rate (%) |
28.26 ± 1.48 | 30.17 ± 2.62 | ns | 29.74 ± 2.23 | 31.78 ± 2.38 | ns |
| LVDevP (%) |
2204.29 ± 355.33 | 1678.49 ± 470.27 | ns | 6025.70 ± 654.65 | 4522.35 ± 742.07 | ns |
| LVEDP (%) |
160.23 ± 9.38 | 158.98 ± 15.10 | ns | 158.26 ± 18.72 | 141.43 ± 9.98 | ns |
| LVESP (%) |
170.36 ± 11.07 | 164.74 ± 16.48 | ns | 171.80 ± 24.07 | 147.96 ± 12.18 | ns |
Data represent the last ten minutes of the RAHF phase and expressed as a percentage of CAHF. LVDevP: left ventricular developed pressure; LVEDP: left ventricular end diastolic pressure; LVESP: left ventricular end systolic pressure; CAHF: critical acute heart failure; RAHF: recovery acute heart failure; Sig.: significance; ns: not significant.